Roche gets U.S. breakthrough tag for liver cancer diagnosis approach

Roche has won fast-track review status in the United States for a new diagnostic approach that the Swiss drugmaker hopes will support its push into treating liver cancer with drugs including its immunotherapy Tecentriq.